Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High and Low Grade Glioma”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06521567
What this trial is testing

Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

Who this might be right for
MelanomaHodgkin LymphomaHigh and Low Grade Glioma+9 more
GlaxoSmithKline 83
Not applicableStudy completedNCT04734444
What this trial is testing

SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue

Who this might be right for
Brain TumourHigh Grade GliomaLow-grade Glioma+1 more
SonoClear AS 45
Testing effectiveness (Phase 2)Study completedNCT00114140
What this trial is testing

Temozolomide and Radiation Therapy in Treating Patients With Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 136
Testing effectiveness (Phase 2)Ended earlyNCT01966809
What this trial is testing

Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 1
Testing effectiveness (Phase 2)Study completedNCT00002463
What this trial is testing

Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors

Who this might be right for
Brain and Central Nervous System Tumors
M.D. Anderson Cancer Center 4
Very early researchLooking for participantsNCT06636162
What this trial is testing

Window of Opportunity Study of DSP-0390 in Gliomas

Who this might be right for
Glioma, MalignantIDH Mutation
Washington University School of Medicine 20
Not applicableStudy completedNCT05873946
What this trial is testing

Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery

Who this might be right for
GliomaGlioma, MalignantLow-grade Glioma+2 more
Hospital del Rio Hortega 99
Early research (Phase 1)Study completedNCT00303940
What this trial is testing

Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorKidney Cancer+5 more
National Institutes of Health Clinical Center (CC) 26
Early research (Phase 1)Study completedNCT00107458
What this trial is testing

Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors

Who this might be right for
Brain and Central Nervous System TumorsUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 26
Early research (Phase 1)Study completedNCT00003141
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors

Who this might be right for
Brain TumorsCentral Nervous System TumorsNeuroblastoma+1 more
Children's Oncology Group 94
Testing effectiveness (Phase 2)Study completedNCT01466686
What this trial is testing

Low Dose Radiation Therapy for Glioblastoma Multiforme

Who this might be right for
High Grade Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 31
Early research (Phase 1)Study completedNCT00063973
What this trial is testing

Cilengitide in Treating Children With Refractory Primary Brain Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+23 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03718767
What this trial is testing

Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype

Who this might be right for
GliomaGlioblastomaHigh Grade Glioma+2 more
National Cancer Institute (NCI) 62
Early research (Phase 1)WithdrawnNCT00458744
What this trial is testing

Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Children's Oncology Group
Not applicableLooking for participantsNCT07832734
What this trial is testing

Metabolomics and Transcriptomics of Low- and High-Grade Gliomas

Who this might be right for
IDH Wildtype GlioblastomaIDH Mutant Lower-Grade Gliomas
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 220
Testing effectiveness (Phase 2)Looking for participantsNCT06712875
What this trial is testing

MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas

Who this might be right for
Low Grade GliomaHigh Grade Glioma
Ann & Robert H Lurie Children's Hospital of Chicago 27
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Testing effectiveness (Phase 2)UnknownNCT00075387
What this trial is testing

Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors

Who this might be right for
Malignant Glioma
OHSU Knight Cancer Institute 48
Early research (Phase 1)Ended earlyNCT00238173
What this trial is testing

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ+1 more
OHSU Knight Cancer Institute 2
Early research (Phase 1)Study completedNCT00100880
What this trial is testing

Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+23 more
National Cancer Institute (NCI) 45
Next Page